TherapeuticsMD, Inc., an inventive pharmaceutical company that focuses on women healthcare, has recently announced that it has presented a New Drug Application (NDA) pre-approval efficacy supplement to the U.S. FDA (Food and Drug Administra....
Cerevel Therapeutics, LLC, a biopharmaceutical company developing new therapies for treating neuroscience diseases, has reportedly dosed healthy volunteers in Phase 1 clinical trial of CVL-936, a potential first-in-class investigational the....
Lamborghini, an Italian car manufacturer renowned for its aesthetically significant, high performance sports cars, is reportedly planning to put his foot down in the Indian automobile sector with its V8 SUV, the Lamborghini Urus. In a rece....
NextGen Healthcare, a renowned electronic health record software developer, reportedly announced its exclusive collaboration with Doctible, a platform that allows healthcare providers to gain real-time feedback from their patients while aut....
Syros Pharmaceuticals, a leading biotechnology company focused upon developing medicines for controlling and altering expression of genes, recently announced that the first patient has been dosed in the clinical trial of SY-5609, with a pot....
Nabis Holdings Inc., is apparently thinking of inking a joint venture (JV) with the Israel company Panaxia Pharmaceutical Industries, Ltd. Reportedly, the MOU signed between the two companies mandates Panaxia to offer proprietary pharma gra....
NantHealth, Inc., a personalized, evidence-based, next-generation healthcare company and NantOmics, LLC, one of the leading companies in molecular analysis, have reportedly launched an innovative AI platform for assisting pathologists in im....
Genentech, Inc., a subsidiary of the Roche Group, has reportedly announced the completion of a sBLA (supplemental Biologics License Application) submission to the U.S. FDA (Food and Drug Administration) for Tecentriq ® (atezolizumab) in....
The U.S. Food and Drug Administration, an agency within the U.S. Department of Health and Human Services, recently issued a safety communication informing patients, health care providers and facilities regarding the cybersecurity vulne....
A clinical stage biotechnology company, PDC*line Pharma, focused upon developing a new class of effective and scalable active immunotherapies for treating cancers, recently announced completion of a Series B round of funding. The ....
© 2024 IntelligenceJournal.com. All Rights Reserved.